France· FR:65336568
IMIPENEM CILASTATINE PANPHARMA 500 mg/500 mg, poudre pour solution pour perfusion
A medicinal product containing imipénem monohydraté + cilastatine sodique, registered in France by PANMEDICA.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- IMIPÉNEM MONOHYDRATÉ + CILASTATINE SODIQUE
- Manufacturer
- PANMEDICA
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip13340095770151210 flacon(s) en verre
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Imipénem monohydraté + cilastatine sodique in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaENAROSMedochemie Ltd., Limassol
- FinlandAndatinMacure Pharma ApS
- SpainENAROS 500 MG/500 MG POLVO PARA SOLUCION PARA PERFUSION EFGMedochemie Limited
- United KingdomImipenem 500mg / Cilastatin 500mg powder for solution for infusion vialsActavis UK Ltd
- United StatesImipenem and CilastatinFresenius Kabi USA, LLC
- GermanyImipenem Cilastatin PanpharmaPanpharma Gmbh
- NetherlandsImipenem/Cilastatine Addimed 500 mg/500 mg poeder voor oplossing voor infusieAddimed Pharma B.V.
- SwedenImipenem/Cilastatin Fresenius Kabi 500 mg/500 mg Pulver till infusionsvätska, lösningFresenius Kabi AB
Authorised across Europe · EMA
The same active substance is authorised in 26 EEA countries. Names it is sold under:
- Austria · Imipenem/Cilastatin Aptapharma, Imipenem/Cilastatin Eberth
- Bulgaria · Имипенем/Циластатин Аптафарма, Мирон
- Cyprus · Imicilast, Imipenem + Cilastatina Venus Pharma
- Czechia · Enaros, Imipenem/Cilastatin Aptapharma
- Germany · Imipenem Cilastatin Panpharma, Imipenem/Cilastatin Basics
- Denmark · Andatin, Imipenem/Cilastatin Noridem
- Estonia · Imipenem/Cilastatin Kabi
- Spain · Enaros, Imipenem/Cilastatina Aurovitas
- Finland · Andatin, Imipenem/Cilastatin Noridem
- United Kingdom (Northern Ireland) · Imipenem/Cilastatin Accord Healthcare, Imipenem/Cilastatin Fresenius Kabi
- Greece · Imicil, Imipenem+cilastatin /Kabi
- Croatia · Imipenem/Cilastatin Aptapharma, Imipenem/Cilastatin Kabi
- Hungary · Imipenem/Cilastatin Aptapharma, Imipenem/Cilastatin Kabi
- Ireland · Imipenem/Cilastatin, Imipenem/Cilastatin Hikma Farmacêutica Portugal
- Italy · Imipenem E Cilastatina Aurobindo, Imipenem E Cilastatina Hikma Farmacêutica
- Lithuania · Imipenem/Cilastatin Sun, Stinem
- Latvia · Imipenem/Cilastatin Sun
- Malta · Imipenem/Cilastatin Aptapharma, Miron
- Netherlands · Imipenem/Cilastatine Fresenius Kabi, Imipenem/Cilastatine Hikma
- Norway · Andatin, Imipenem/Cilastatin Fresenius Kabi
- Poland · Imipenem + Cilastatin Aptapharma, Imipenem + Cilastatin Noridem
- Portugal · Enaros, Imipenem + Cilastatina Aurovitas
- Romania · Cilopen, Imipenem/Cilastatin Aptapharma
- Sweden · Imipenem/Cilastatin Fresenius Kabi, Imipenem/Cilastatin Noridem
- Slovenia · Imipenem/Cilastatin Aptapharma, Imipenem/Cilastatin Kabi
- Slovakia · Imipenem/Cilastatin Aptapharma, Imipenem/Cilastatin Kabi
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/af41bd47-a8e7-4b5c-82df-0fa14dc9ab29 GET /v1/drugs/af41bd47-a8e7-4b5c-82df-0fa14dc9ab29?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "65336568",
"date_amm": "2010-04-26",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "IMIPÉNEM MONOHYDRATÉ + CILASTATINE SODIQUE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "poudre pour solution pour perfusion",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about imipénem monohydraté + cilastatine sodique.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.